In Memoriam: Philip E. Thorpe, Ph.D., 1951 – 2013
The entire UT Southwestern Medical Center community mourns Dr. Thorpe's passing. His achievements in drug targeting, angiogenesis, and antibody-based therapeutics had a global impact, and his loss will be felt deeply on our campus and well beyond. Dr. Thorpe’s research focused on the development of novel drugs targeting tumor blood vessels. His laboratory made the remarkable discovery that a fatty lipid molecule, phosphatidylserine, is preferentially expressed on cancer blood vessels, where it can serve as a target to increase the specificity of drugs to the tumor.